Researchers evaluate the ability of structured information-sharing networks among clinicians to improve clinicians’ diagnostic accuracy and treatment decisions.
AGEPHA Pharma’s LODOCO receives US FDA approval
LODOCO is indicated for reducing the risk of stroke, myocardial infarction and cardiovascular death in adult ASCVD patients. Credit: AGEPHA Pharma/ Business Wire. AGEPHA Pharma